2 Patents
- US125954702026Engineered Nucleases That Target Human and Canine Factor VIII Genes as a Treatment for Hemophilia A
Precision Biosciences, Inc.
0 cites - US124486132025Genetically-modified T Cells Comprising a Modified Intron in the T Cell Receptor Alpha Gene
Precision Biosciences, Inc.
0 cites